'Information is information': A public perspective on incidental findings in clinical and research genome-based testing

S. Daack-Hirsch, Martha Driessnack, A. Hanish, Va Johnson, Ll Shah, Cm Simon, Jk Williams

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The potential for genomic incidental findings is increasing with the use of genome-based testing. At the same time approaches to clinical decision making are shifting to shared decision-making models involving both the healthcare community and the public. The public's voice has been nearly absent in discussions on managing incidental findings. We conducted nine focus groups and nine interviews (n=63) with a broad cross-section of lay public groups to elucidate public viewpoints on incidental findings that could occur as a result of genome-based testing in clinical and research situations. Data were analyzed using qualitative content analysis. Participants wanted incidental findings disclosed to them whether or not these were clinical or research findings. Participants used different terms to define and describe incidental findings; they wanted to know that incidental findings are possible and be given a choice to learn about them. Personal utility was an important reason for disclosure, and participants believed that managing information is a shared responsibility between professionals and themselves. Broad public input is needed in order to understand and incorporate the public's perspective on management of incidental findings as disclosure guidelines, and policies are developed in clinical and research settings.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalClinical Genetics
Volume84
Issue number1
DOIs
StatePublished - Jul 2013

Fingerprint

Incidental Findings
Genome
Research
Disclosure
Focus Groups
Decision Making
Guidelines
Interviews
Delivery of Health Care

Keywords

  • Genome-based testing
  • Incidental findings
  • Personal utility
  • Public perspective

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

'Information is information' : A public perspective on incidental findings in clinical and research genome-based testing. / Daack-Hirsch, S.; Driessnack, Martha; Hanish, A.; Johnson, Va; Shah, Ll; Simon, Cm; Williams, Jk.

In: Clinical Genetics, Vol. 84, No. 1, 07.2013, p. 11-18.

Research output: Contribution to journalArticle

Daack-Hirsch, S. ; Driessnack, Martha ; Hanish, A. ; Johnson, Va ; Shah, Ll ; Simon, Cm ; Williams, Jk. / 'Information is information' : A public perspective on incidental findings in clinical and research genome-based testing. In: Clinical Genetics. 2013 ; Vol. 84, No. 1. pp. 11-18.
@article{04bd44a085e447ff9de9053d58feaa86,
title = "'Information is information': A public perspective on incidental findings in clinical and research genome-based testing",
abstract = "The potential for genomic incidental findings is increasing with the use of genome-based testing. At the same time approaches to clinical decision making are shifting to shared decision-making models involving both the healthcare community and the public. The public's voice has been nearly absent in discussions on managing incidental findings. We conducted nine focus groups and nine interviews (n=63) with a broad cross-section of lay public groups to elucidate public viewpoints on incidental findings that could occur as a result of genome-based testing in clinical and research situations. Data were analyzed using qualitative content analysis. Participants wanted incidental findings disclosed to them whether or not these were clinical or research findings. Participants used different terms to define and describe incidental findings; they wanted to know that incidental findings are possible and be given a choice to learn about them. Personal utility was an important reason for disclosure, and participants believed that managing information is a shared responsibility between professionals and themselves. Broad public input is needed in order to understand and incorporate the public's perspective on management of incidental findings as disclosure guidelines, and policies are developed in clinical and research settings.",
keywords = "Genome-based testing, Incidental findings, Personal utility, Public perspective",
author = "S. Daack-Hirsch and Martha Driessnack and A. Hanish and Va Johnson and Ll Shah and Cm Simon and Jk Williams",
year = "2013",
month = "7",
doi = "10.1111/cge.12167",
language = "English (US)",
volume = "84",
pages = "11--18",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - 'Information is information'

T2 - A public perspective on incidental findings in clinical and research genome-based testing

AU - Daack-Hirsch, S.

AU - Driessnack, Martha

AU - Hanish, A.

AU - Johnson, Va

AU - Shah, Ll

AU - Simon, Cm

AU - Williams, Jk

PY - 2013/7

Y1 - 2013/7

N2 - The potential for genomic incidental findings is increasing with the use of genome-based testing. At the same time approaches to clinical decision making are shifting to shared decision-making models involving both the healthcare community and the public. The public's voice has been nearly absent in discussions on managing incidental findings. We conducted nine focus groups and nine interviews (n=63) with a broad cross-section of lay public groups to elucidate public viewpoints on incidental findings that could occur as a result of genome-based testing in clinical and research situations. Data were analyzed using qualitative content analysis. Participants wanted incidental findings disclosed to them whether or not these were clinical or research findings. Participants used different terms to define and describe incidental findings; they wanted to know that incidental findings are possible and be given a choice to learn about them. Personal utility was an important reason for disclosure, and participants believed that managing information is a shared responsibility between professionals and themselves. Broad public input is needed in order to understand and incorporate the public's perspective on management of incidental findings as disclosure guidelines, and policies are developed in clinical and research settings.

AB - The potential for genomic incidental findings is increasing with the use of genome-based testing. At the same time approaches to clinical decision making are shifting to shared decision-making models involving both the healthcare community and the public. The public's voice has been nearly absent in discussions on managing incidental findings. We conducted nine focus groups and nine interviews (n=63) with a broad cross-section of lay public groups to elucidate public viewpoints on incidental findings that could occur as a result of genome-based testing in clinical and research situations. Data were analyzed using qualitative content analysis. Participants wanted incidental findings disclosed to them whether or not these were clinical or research findings. Participants used different terms to define and describe incidental findings; they wanted to know that incidental findings are possible and be given a choice to learn about them. Personal utility was an important reason for disclosure, and participants believed that managing information is a shared responsibility between professionals and themselves. Broad public input is needed in order to understand and incorporate the public's perspective on management of incidental findings as disclosure guidelines, and policies are developed in clinical and research settings.

KW - Genome-based testing

KW - Incidental findings

KW - Personal utility

KW - Public perspective

UR - http://www.scopus.com/inward/record.url?scp=84879793625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879793625&partnerID=8YFLogxK

U2 - 10.1111/cge.12167

DO - 10.1111/cge.12167

M3 - Article

C2 - 23590238

AN - SCOPUS:84879793625

VL - 84

SP - 11

EP - 18

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -